1
|
Fronza MG, Ferreira BF, Pavan-Silva I, Guimarães FS, Lisboa SF. "NO" Time in Fear Response: Possible Implication of Nitric-Oxide-Related Mechanisms in PTSD. Molecules 2023; 29:89. [PMID: 38202672 PMCID: PMC10779493 DOI: 10.3390/molecules29010089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Revised: 12/05/2023] [Accepted: 12/20/2023] [Indexed: 01/12/2024] Open
Abstract
Post-traumatic stress disorder (PTSD) is a psychiatric condition characterized by persistent fear responses and altered neurotransmitter functioning due to traumatic experiences. Stress predominantly affects glutamate, a neurotransmitter crucial for synaptic plasticity and memory formation. Activation of the N-Methyl-D-Aspartate glutamate receptors (NMDAR) can trigger the formation of a complex comprising postsynaptic density protein-95 (PSD95), the neuronal nitric oxide synthase (nNOS), and its adaptor protein (NOS1AP). This complex is pivotal in activating nNOS and nitric oxide (NO) production, which, in turn, activates downstream pathways that modulate neuronal signaling, including synaptic plasticity/transmission, inflammation, and cell death. The involvement of nNOS and NOS1AP in the susceptibility of PTSD and its comorbidities has been widely shown. Therefore, understanding the interplay between stress, fear, and NO is essential for comprehending the maintenance and progression of PTSD, since NO is involved in fear acquisition and extinction processes. Moreover, NO induces post-translational modifications (PTMs), including S-nitrosylation and nitration, which alter protein function and structure for intracellular signaling. Although evidence suggests that NO influences synaptic plasticity and memory processing, the specific role of PTMs in the pathophysiology of PTSD remains unclear. This review highlights pathways modulated by NO that could be relevant to stress and PTSD.
Collapse
Affiliation(s)
- Mariana G. Fronza
- Pharmacology Departament, Ribeirão Preto Medical School, University of São Paulo, São Paulo 14049-900, Brazil; (M.G.F.); (B.F.F.); (I.P.-S.)
| | - Bruna F. Ferreira
- Pharmacology Departament, Ribeirão Preto Medical School, University of São Paulo, São Paulo 14049-900, Brazil; (M.G.F.); (B.F.F.); (I.P.-S.)
| | - Isabela Pavan-Silva
- Pharmacology Departament, Ribeirão Preto Medical School, University of São Paulo, São Paulo 14049-900, Brazil; (M.G.F.); (B.F.F.); (I.P.-S.)
| | - Francisco S. Guimarães
- Pharmacology Departament, Ribeirão Preto Medical School, University of São Paulo, São Paulo 14049-900, Brazil; (M.G.F.); (B.F.F.); (I.P.-S.)
| | - Sabrina F. Lisboa
- Pharmacology Departament, Ribeirão Preto Medical School, University of São Paulo, São Paulo 14049-900, Brazil; (M.G.F.); (B.F.F.); (I.P.-S.)
- Biomolecular Sciences Department, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo 14040-903, Brazil
| |
Collapse
|
2
|
Fronza MG, Alves D, Praticò D, Savegnago L. The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer's disease. Ageing Res Rev 2023; 90:102033. [PMID: 37595640 DOI: 10.1016/j.arr.2023.102033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2023] [Revised: 08/04/2023] [Accepted: 08/14/2023] [Indexed: 08/20/2023]
Abstract
Alzheimer's Disease (AD) is the most common form of dementia, affecting almost 50 million of people around the world, characterized by a complex and age-related progressive pathology with projections to duplicate its incidence by the end of 2050. AD pathology has two major hallmarks, the amyloid beta (Aβ) peptides accumulation and tau hyperphosphorylation, alongside with several sub pathologies including neuroinflammation, oxidative stress, loss of neurogenesis and synaptic dysfunction. In recent years, extensive research pointed out several therapeutic targets which have shown promising effects on modifying the course of the disease in preclinical models of AD but with substantial failure when transposed to clinic trials, suggesting that modulating just an isolated feature of the pathology might not be sufficient to improve brain function and enhance cognition. In line with this, there is a growing consensus that an ideal disease modifying drug should address more than one feature of the pathology. Considering these evidence, β-secretase (BACE1), Glycogen synthase kinase 3β (GSK-3β) and acetylcholinesterase (AChE) has emerged as interesting therapeutic targets. BACE1 is the rate-limiting step in the Aβ production, GSK-3β is considered the main kinase responsible for Tau hyperphosphorylation, and AChE play an important role in modulating memory formation and learning. However, the effects underlying the modulation of these enzymes are not limited by its primarily functions, showing interesting effects in a wide range of impaired events secondary to AD pathology. In this sense, this review will summarize the involvement of BACE1, GSK-3β and AChE on synaptic function, neuroplasticity, neuroinflammation and oxidative stress. Additionally, we will present and discuss new perspectives on the modulation of these pathways on AD pathology and future directions on the development of drugs that concomitantly target these enzymes.
Collapse
Affiliation(s)
- Mariana G Fronza
- Neurobiotechnology Research Group (GPN) - Centre for Technology Development CDTec, Federal University of Pelotas (UFPel), Pelotas, RS, Brazil
| | - Diego Alves
- Laboratory of Clean Organic Synthesis (LASOL), Center for Chemical, Pharmaceutical and Food Sciences (CCQFA), UFPel, RS, Brazil
| | - Domenico Praticò
- Alzheimer's Center at Temple - ACT, Temple University, Lewis Katz School of Medicine, Philadelphia, PA, United States
| | - Lucielli Savegnago
- Neurobiotechnology Research Group (GPN) - Centre for Technology Development CDTec, Federal University of Pelotas (UFPel), Pelotas, RS, Brazil.
| |
Collapse
|
3
|
Fronza MG, Sacramento M, Alves D, Praticò D, Savegnago L. QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice. Mol Neurobiol 2023; 60:1733-1745. [PMID: 36567360 DOI: 10.1007/s12035-022-03159-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2022] [Accepted: 12/01/2022] [Indexed: 12/27/2022]
Abstract
Growing evidence has associated major depressive disorder (MDD) as a risk factor or prodromal syndrome for the occurrence of Alzheimer's disease (AD). Although this dilemma remains open, it is widely shown that a lifetime history of MDD is correlated with faster progression of AD pathology. Therefore, antidepressant drugs with neuroprotective effects could be an interesting therapeutic conception to target this issue simultaneously. In this sense, 1-(7-chloroquinolin-4-yl)-N-(4-methoxybenzyl)-5-methyl-1H-1,2,3-triazole-4- carboxamide (QTC-4-MeOBnE) was initially conceived as a multi-target ligand with affinity to β-secretase (BACE), glycogen synthase kinase 3β (GSK3β), and acetylcholinesterase but has also shown secondary effects on pathways involved in neuroinflammation and neurogenesis in preclinical models of AD. Herein, we investigated the effect of QTC-4-MeOBnE (1 mg/kg) administration for 45 days on depressive-like behavior and memory impairment in 3xTg mice, before the pathology is completely established. The treatment with QTC-4-MeOBnE prevented memory impairment and depressive-like behavior assessed by the Y-Maze task and forced swimming test. This effect was associated with the modulation of plural pathways involved in the onset and progression of AD, in cerebral structures of the cortex and hippocampus. Among them, the reduction of amyloid beta (Aβ) production mediated by changes in amyloid precursor protein metabolism and hippocampal tau phosphorylation through the inhibition of kinases. Additionally, QTC-4-MeOBnE also exerted beneficial effects on neuroinflammation and synaptic integrity. Overall, our studies suggest that QTC-4-MeOBnE has a moderate effect in a transgenic model of AD, indicating that perhaps studies regarding the neuropsychiatric effects as a neuroprotective molecule are more prone to be feasible.
Collapse
Affiliation(s)
- Mariana G Fronza
- Neurobiotechnology Research Group (GPN) - Postgraduate Program of Biotechnology, Federal University of Pelotas (UFPel), Pelotas, RS, Brazil
| | - Manoela Sacramento
- Laboratory of Clean Organic Synthesis (LASOL), Postgraduate Program of Chemistry, UFPel, Pelotas, RS, Brazil
| | - Diego Alves
- Laboratory of Clean Organic Synthesis (LASOL), Postgraduate Program of Chemistry, UFPel, Pelotas, RS, Brazil
| | - Domenico Praticò
- Alzheimer's Center at Temple - ACT, Temple University, Lewis Katz School of Medicine, Philadelphia, PA, USA
| | - Lucielli Savegnago
- Neurobiotechnology Research Group (GPN) - Postgraduate Program of Biotechnology, Federal University of Pelotas (UFPel), Pelotas, RS, Brazil.
| |
Collapse
|
4
|
Larroza A, Krüger R, Fronza MG, Pesarico AP, de Oliveira DH, Savegnago L, Alves D. Synthesis of sulfamoyl-triazolyl-carboxamides as pharmacological myeloperoxidase inhibitors. NEW J CHEM 2022. [DOI: 10.1039/d2nj01926d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Sulfamoyl-triazolyl-carboxamides were synthesized using DBU as a catalyst, and their molecular docking and MPO activity analyses were performed.
Collapse
Affiliation(s)
- Allya Larroza
- Laboratório de Síntese Orgânica Limpa – LASOL, CCQFA, Universidade Federal de Pelotas – UFPel, P. O. Box 354, 96010-900, Pelotas, RS, Brazil
| | - Roberta Krüger
- Laboratório de Síntese Orgânica Limpa – LASOL, CCQFA, Universidade Federal de Pelotas – UFPel, P. O. Box 354, 96010-900, Pelotas, RS, Brazil
| | - Mariana G. Fronza
- Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas - UFPel, Pelotas, RS, Brazil
| | - Ana Paula Pesarico
- Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas - UFPel, Pelotas, RS, Brazil
| | - Daniela H. de Oliveira
- Laboratório de Síntese Orgânica Limpa – LASOL, CCQFA, Universidade Federal de Pelotas – UFPel, P. O. Box 354, 96010-900, Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas - UFPel, Pelotas, RS, Brazil
| | - Diego Alves
- Laboratório de Síntese Orgânica Limpa – LASOL, CCQFA, Universidade Federal de Pelotas – UFPel, P. O. Box 354, 96010-900, Pelotas, RS, Brazil
| |
Collapse
|
5
|
Fronza MG, Baldinotti R, Fetter J, Rosa SG, Sacramento M, Nogueira CW, Alves D, Praticò D, Savegnago L. Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: The role of blood-brain barrier permeability, NF-κB signaling, and microglial activation. Brain Behav Immun 2022; 99:177-191. [PMID: 34624485 DOI: 10.1016/j.bbi.2021.10.002] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Revised: 09/29/2021] [Accepted: 10/01/2021] [Indexed: 12/11/2022] Open
Abstract
Clinical and preclinical investigations have suggested a possible biological link betweenmajor depressive disorder (MDD) and Alzheimer's disease (AD). Therefore, a pharmacologic approach to treating MDD could be envisioned as a preventative therapy for some AD cases. In line with this, 1-(7-chloroquinolin-4-yl)-N-(4-methoxybenzyl)-5-methyl-1H-1,2,3-triazole-4 carboxamide (QTC-4-MeOBnE) is characterized as an inhibitor of β-secretase, glycogen synthase kinase 3β, and acetylcholinesterase and has also shown secondary effects underlying the modulation of neurogenesis and synaptic plasticity pathways. Therefore, we investigated the effects of QTC-4-MeOBnE treatment (0.1 or 1 mg/kg) on depressive-like behavior and cognitive impairments elicited by repeated injections of lipopolysaccharide (LPS; 250 μg/kg) in mice. Injections of LPS for seven days led to memory impairments and depressive-like behavior, as evidenced in the Y-maze/object recognition test and forced swimming/splash tests, respectively. However, these impairments were prevented in mice that, after the last LPS injection, were also treated with QTC-4-MeOBnE (1 mg/kg). This effect was associated with restoring blood-brain barrier permeability, reducing oxidative/nitrosative biomarkers, and decreasing neuroinflammation mediated NF-κB signaling in the hippocampus and cortex of the mice. To further investigate the involvement with NF-κB signaling, we evaluated the effects of QTC-4-MeOBnE on microglial cell activation through canonical and non-canonical pathways and the modulation of the involved components. Together, our findings highlight the pharmacological benefits of QTC-4-MeOBnE in a mouse model of sickness behavior and memory impairments, supporting the novel concept that since this molecule produces anti-depressant activity, it could also be beneficial for preventing AD onset and related dementias in subjects suffering from MDD through inflammatory pathway modulation.
Collapse
Affiliation(s)
- Mariana G Fronza
- Neurobiotechnology Research Group (GPN) - Centre for Technology Development CDTec, Federal University of Pelotas (UFPel), Pelotas, RS, Brazil
| | - Rodolfo Baldinotti
- Neurobiotechnology Research Group (GPN) - Centre for Technology Development CDTec, Federal University of Pelotas (UFPel), Pelotas, RS, Brazil
| | - Jenifer Fetter
- Neurobiotechnology Research Group (GPN) - Centre for Technology Development CDTec, Federal University of Pelotas (UFPel), Pelotas, RS, Brazil
| | - Suzan Gonçalves Rosa
- Laboratory of Synthesis, Reactivity and Pharmacological and Toxicological Evaluation of Organocalcogens, Center for Natural and Exact Sciences, Federal University of Santa Maria, UFSM, Santa Maria, RS, Brazil
| | - Manoela Sacramento
- Laboratory of Clean Organic Synthesis (LASOL), Center for Chemical, Pharmaceutical and Food Sciences (CCQFA), UFPel, RS, Brazil
| | - Cristina Wayne Nogueira
- Laboratory of Synthesis, Reactivity and Pharmacological and Toxicological Evaluation of Organocalcogens, Center for Natural and Exact Sciences, Federal University of Santa Maria, UFSM, Santa Maria, RS, Brazil
| | - Diego Alves
- Laboratory of Clean Organic Synthesis (LASOL), Center for Chemical, Pharmaceutical and Food Sciences (CCQFA), UFPel, RS, Brazil
| | - Domenico Praticò
- Alzheimer's Center at Temple - ACT, Temple University, Lewis Katz School of Medicine, Philadelphia, PA, United States
| | - Lucielli Savegnago
- Neurobiotechnology Research Group (GPN) - Centre for Technology Development CDTec, Federal University of Pelotas (UFPel), Pelotas, RS, Brazil.
| |
Collapse
|
6
|
Krüger R, Larroza A, Fronza MG, Tisoco I, Savegnago L, Reis JS, Back DF, Iglesias BA, Alves D. Bis-triazolylchalcogenium-Functionalized Benzothiadiazole Derivatives as Light-up Sensors for DNA and BSA. J Org Chem 2021; 86:17866-17883. [PMID: 34843245 DOI: 10.1021/acs.joc.1c02153] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
A range of bis-triazolylchalcogenium-BTD 3 was synthesized by a copper-catalyzed azide-alkyne cycloaddition of azido arylchalcogenides 1 and 4,7-diethynylbenzo[c][1,2,5]thiadiazole 2. Eight new compounds were obtained in moderate to good yields using 1 mol % of copper(II) acetate monohydrate under mild reaction conditions. In addition, the synthesized bis-triazolylchalcogenium-BTD 3a-3h were investigated regarding their photophysical, electrochemical, and biomolecule binding properties in solution. In general, compounds presented strong absorption bands at the 250-450 nm region and cyan to green emission properties. The redox process attributed to the chalcogen atom was observed by electrochemical analysis (CV techniques). In addition, spectroscopic studies by UV-vis, steady-state emission fluorescence, and molecular docking calculations evidenced the ability of each derivative to establish interactions with calf-thymus DNA (CT-DNA) and bovine serum albumin (BSA). The behavior presented for this new class of compounds makes them a promising tool as optical sensors for biomolecules.
Collapse
Affiliation(s)
- Roberta Krüger
- Clean Organic Synthesis Laboratory - LASOL - CCQFA - Federal University of Pelotas - UFPel, CEP, 96010-900 Pelotas, RS, Brazil
| | - Allya Larroza
- Clean Organic Synthesis Laboratory - LASOL - CCQFA - Federal University of Pelotas - UFPel, CEP, 96010-900 Pelotas, RS, Brazil
| | - Mariana G Fronza
- Neurobiotechnology Research Group - GPN, CDTec, Federal University of Pelotas, UFPel, CEP, 96010-900 Pelotas, RS, Brazil
| | - Isadora Tisoco
- Chemistry Department, Bioinorganics and Porphyrinic Materials Laboratory, Federal University of Santa Maria, UFSM, CEP, 97105-900 Santa Maria, RS, Brazil
| | - Lucielli Savegnago
- Neurobiotechnology Research Group - GPN, CDTec, Federal University of Pelotas, UFPel, CEP, 96010-900 Pelotas, RS, Brazil
| | - Joel S Reis
- Institute of Chemistry, Fluminense Federal University, UFF, CEP, 24020-141 Niteroi, RJ, Brazil
| | - Davi F Back
- Chemistry Department, Inorganic Materials Laboratory, Federal University of Santa Maria, UFSM, CEP, 97105-900 Santa Maria, RS, Brazil
| | - Bernardo A Iglesias
- Chemistry Department, Bioinorganics and Porphyrinic Materials Laboratory, Federal University of Santa Maria, UFSM, CEP, 97105-900 Santa Maria, RS, Brazil
| | - Diego Alves
- Clean Organic Synthesis Laboratory - LASOL - CCQFA - Federal University of Pelotas - UFPel, CEP, 96010-900 Pelotas, RS, Brazil
| |
Collapse
|
7
|
Baldinotti R, Fronza MG, Fetter J, Silva L, Bender CB, Lüdtke DS, Seixas FK, Collares T, Alves D, Savegnago L. Protective effects of octylseleno-xylofuranoside in a streptozotocin-induced mouse model of Alzheimer's disease. Eur J Pharmacol 2021; 910:174499. [PMID: 34508753 DOI: 10.1016/j.ejphar.2021.174499] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Revised: 08/27/2021] [Accepted: 09/06/2021] [Indexed: 10/20/2022]
Abstract
Octylseleno-xylofuranoside (OSX) is an organic selenium compound which has previously shown antioxidant and antidepressant-like activities, trough the modulation of monoaminergic system and synaptic plasticity pathways. Since recent studies have suggested Major Depressive Disorder (MDD) as a potential risk factor or condition that precedes and correlates with Alzheimer's Disease (AD), this study aimed to evaluate the protective effects of OSX in an AD mouse model induced by intracerebroventricular injection of streptozotocin (STZ). To address this protective effect, mice were pre-treated with intragastrical OSX (0.1 mg/kg) or vehicle for 20 days. After the pre-treatment, mice were submitted to two alternated intracerebroventricular infusions of STZ (days 21 and 23) or saline. 15 days after the last STZ injection, cognitive and memory skills of the treated mice were evaluated on object recognition test, Y-maze, stepdown passive avoidance and social recognition paradigms. Added to that, measurements of oxidative stress markers and gene expression were evaluated in brain samples of the same mice groups. Mice pre-treatment with OSX protected mice from cognitive and memory decline elicited by STZ. This effect was attributed to the prevention of lipid peroxidation and modulation of acetylcholinesterase and monoamine oxidase activities in cerebral cortices and hippocampi by OSX treatment. Furthermore, OSX treatment demonstrated reduction of amyloidogenic pathway genes expression when compared to the control groups. Besides that, OSX treatment showed no hepatic and renal toxicity in the protocol used for treatment. Considering the antidepressant-like effect of OSX, together with the ability to prevent memory and cognitive impairment, this new compound may be an interesting strategy for targeting the comorbidity between MDD and AD, in a multitarget drug paradigm.
Collapse
Affiliation(s)
- Rodolfo Baldinotti
- Neurobiotechnology Research Group, Postgraduate Program in Biotechnology, Technologic Development Center, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Mariana G Fronza
- Neurobiotechnology Research Group, Postgraduate Program in Biotechnology, Technologic Development Center, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Jenifer Fetter
- Neurobiotechnology Research Group, Postgraduate Program in Biotechnology, Technologic Development Center, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Luana Silva
- Chemical Institute, Laboratory of Molecular Catalysis, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
| | - Camila Bonemann Bender
- Technological Development Center, Division of Biotechnology, Molecular and Cellular Oncology Research Group and Cancer Biotechnology Laboratory, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Diogo Seibert Lüdtke
- Chemical Institute, Laboratory of Molecular Catalysis, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
| | - Fabiana K Seixas
- Technological Development Center, Division of Biotechnology, Molecular and Cellular Oncology Research Group and Cancer Biotechnology Laboratory, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Tiago Collares
- Technological Development Center, Division of Biotechnology, Molecular and Cellular Oncology Research Group and Cancer Biotechnology Laboratory, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Diego Alves
- Center for Chemical, Pharmaceutical and Food Sciences, Laboratory of Clean Organic Synthesis, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Neurobiotechnology Research Group, Postgraduate Program in Biotechnology, Technologic Development Center, Federal University of Pelotas, Pelotas, RS, Brazil.
| |
Collapse
|
8
|
Fronza MG, Baldinotti R, Sacramento M, Gutierres J, Carvalho FB, Fernandes MDC, Sousa FSS, Seixas FK, Collares T, Alves D, Pratico D, Savegnago L. Effect of QTC-4-MeOBnE Treatment on Memory, Neurodegeneration, and Neurogenesis in a Streptozotocin-Induced Mouse Model of Alzheimer's Disease. ACS Chem Neurosci 2021; 12:109-122. [PMID: 33315382 DOI: 10.1021/acschemneuro.0c00615] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Growing evidence suggests that drugs targeting neurogenesis and myelinization could be novel therapeutic targets against Alzheimer's disease (AD). Intracerebroventricular (icv) injection of streptozotocin (STZ) induces neurodegeneration through multiple mechanisms ultimately resulting in reduced adult neurogenesis. Previously, the multitarget compound QTC-4-MeOBnE (1-(7-chloroquinolin-4-yl)-N-(4-methoxybenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide) demonstrated beneficial effects in preclinical models of AD. Here we investigated its pharmacokinetics profile and the effect on memory impairments and neurodegeneration induced by STZ. Two icv injections of STZ resulted in significant cognitive and memory impairments, assessed by novel object recognition, Y-maze, social recognition, and step-down passive avoidance paradigms. These deficits were reversed in STZ-injected mice treated with QTC-4-MeOBnE. This effect was associated with reversion of neuronal loss in hippocampal dentate gyrus, reduced oxidative stress, and amelioration of synaptic function trough Na+/K+ ATPase and acetylcholinesterase activities. Furthermore, brains from QTC-4-MeOBnE-treated mice had a significant increase in adult neurogenesis and remyelination through Prox1/NeuroD1 and Wnt/β-catenin pathways. Overall, our findings support the potential anti-AD effect of QTC-4-MeOBnE through multiple pathways, all of which have been involved in the onset and progression of the disease.
Collapse
Affiliation(s)
- Mariana G. Fronza
- Research Group on Neurobiotechnology−GPN, Technological Development Center (CDTec), Federal University of Pelotas (UFPel), Pelotas, RS 96010-610, Brazil
| | - Rodolfo Baldinotti
- Research Group on Neurobiotechnology−GPN, Technological Development Center (CDTec), Federal University of Pelotas (UFPel), Pelotas, RS 96010-610, Brazil
| | - Manoela Sacramento
- Laboratory of Clean Organic Synthesis−LASOL, Center for Chemical, Pharmaceutical and Food Sciences (CCQFA), UFPel, Pelotas, RS 96010-610, Brazil
| | - Jessié Gutierres
- Pathology Laboratory, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS 90050-170, Brazil
| | - Fabiano Barbosa Carvalho
- Pathology Laboratory, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS 90050-170, Brazil
| | - Marilda da Cruz Fernandes
- Pathology Laboratory, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS 90050-170, Brazil
| | | | - Fabiana K. Seixas
- Oncology Research Group, GPO, CDTec, UFPel, CDTec, Pelotas, RS 96010-610, Brazil
| | - Tiago Collares
- Oncology Research Group, GPO, CDTec, UFPel, CDTec, Pelotas, RS 96010-610, Brazil
| | - Diego Alves
- Laboratory of Clean Organic Synthesis−LASOL, Center for Chemical, Pharmaceutical and Food Sciences (CCQFA), UFPel, Pelotas, RS 96010-610, Brazil
| | - Domenico Pratico
- Alzheimer’s Center at Temple−ACT, Temple University, Lewis Katz School of Medicine, Philadelphia, Pennsylvania 19140, United States of America
| | - Lucielli Savegnago
- Research Group on Neurobiotechnology−GPN, Technological Development Center (CDTec), Federal University of Pelotas (UFPel), Pelotas, RS 96010-610, Brazil
| |
Collapse
|
9
|
Costa GP, Dias ÍFC, Fronza MG, Besckow EM, Fetter J, Nascimento JER, Jacob RG, Savegnago L, Bortolatto CF, Brüning CA, Alves D. Synthesis of 2′-(1,2,3-triazoyl)-acetophenones: molecular docking and inhibition of in vitro monoamine oxidase activity. NEW J CHEM 2021. [DOI: 10.1039/d0nj04735j] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The synthesis of 2′-(1,2,3-triazoyl)-acetophenones by a CuAAC using thiourea as a ligand, molecular docking and MAO activity analyses were performed.
Collapse
|
10
|
Oliveira Rocha AM, Severo Sabedra Sousa F, Mascarenhas Borba V, S Munchen T, Guerin Leal J, Dorneles Rodrigues OE, G Fronza M, Savegnago L, Collares T, Kömmling Seixas F. Evaluation of the effect of synthetic compounds derived from azidothymidine on MDA-MB-231 type breast cancer cells. Bioorg Med Chem Lett 2020; 30:127365. [PMID: 32738968 DOI: 10.1016/j.bmcl.2020.127365] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Revised: 06/19/2020] [Accepted: 06/20/2020] [Indexed: 12/19/2022]
Abstract
The present study aimed to investigate the effect of AZT derivates containing tellurium (Te) on human breast cancer cell lines and the mechanisms underlying cell death. The inhibitory effect of AZT and its derivatives (7m and 7r) was determined by the MTT assay (6.25, 12.5, 25, 50 and 100 μM in 24 and 48 h time points), meanwhile the induction of apoptosis and the cell cycle phases was investigated by flow cytometry. The MTT assay showed that AZT derivatives decreased the rate of cell proliferation at concentrations of 12.5 μM, while commercial AZT showed low antitumor potential. In flow cytometric analysis, we demonstrate that the AZT derivatives do not induce apoptosis at the concentration tested and promote the cell cycle arrest in the S phase. Besides, predicted absorption, distribution, metabolization, excretion and toxicity analysis suggest that the compounds possess a good pharmacokinetic profile and possibly less toxicity when compared to conventional AZT. These compounds containing tellurium in their formulation are potential therapeutic agents for breast cancer.
Collapse
Affiliation(s)
- Adriely Maria Oliveira Rocha
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Fernanda Severo Sabedra Sousa
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Victoria Mascarenhas Borba
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Taiana S Munchen
- Department of Biochemistry and Molecular Biology, Center for Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - Julliano Guerin Leal
- Department of Biochemistry and Molecular Biology, Center for Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - Oscar Endrigo Dorneles Rodrigues
- Department of Biochemistry and Molecular Biology, Center for Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - Mariana G Fronza
- Postgraduate Program in Biotechnology (PPGB), Neurobiotechnology Research Group, Technological Development Center, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Postgraduate Program in Biotechnology (PPGB), Neurobiotechnology Research Group, Technological Development Center, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Tiago Collares
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Fabiana Kömmling Seixas
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil.
| |
Collapse
|
11
|
Bampi SR, Casaril AM, Fronza MG, Domingues M, Vieira B, Begnini KR, Seixas FK, Collares TV, Lenardão EJ, Savegnago L. The selenocompound 1-methyl-3-(phenylselanyl)-1H-indole attenuates depression-like behavior, oxidative stress, and neuroinflammation in streptozotocin-treated mice. Brain Res Bull 2020; 161:158-165. [PMID: 32470357 DOI: 10.1016/j.brainresbull.2020.05.008] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2019] [Revised: 04/08/2020] [Accepted: 05/15/2020] [Indexed: 12/22/2022]
Abstract
Major depressive disorder (MDD) is a chronic mental illness affecting a wide range of people worldwide. The pathophysiology of MDD is not completely elucidated, but it is believed that oxidative stress and neuroinflammation are involved. In light with this, the aim of the present study was to investigate whether a single administration of the antioxidant 1-methyl-3-(phenylselanyl)-1H-indole (MFSeI) was able to reverse the streptozotocin-induced depression-like behavior, oxidative stress, and neuroinflammation in mice. MFSeI (10 mg/kg) was administered intragastrically (i.g.) 24 h after the intracerebroventricular injection of STZ (0.2 mg/4 μL/per mouse). Thirty minutes after MFSeI administration, behavioral tests and neurochemical analyses were performed. Fluoxetine (10 mg/kg, i.g.) was used as a positive control. MFSeI and fluoxetine were able to reverse the STZ-induced depression-like behavior, as evidenced by decreased immobility time in the forced swimming test and increased grooming time in the splash test. Mechanistically, MFSeI reversed the increased levels of reactive species and lipid peroxidation in the prefrontal cortices and hippocampi of STZ-treated mice. Additionally, neuroinflammation (i.e. expression of NF-κB, IL-1β, and TNF-α) and the reduced mRNA levels of BDNF in the and hippocampi of depressed mice were reversed by treatment with MFSeI. Fluoxetine did not improve the STZ-induced alterations at the levels of reactive species, NF-κB and BDNF in the prefrontal cortices neither the levels of TNF-α in both brain regions. Together, these data suggest that the MFSeI may be a promising compound with antidepressant-like action, reducing oxidative stress and modulating inflammatory pathways in the brain of depressed mice.
Collapse
Affiliation(s)
- Suely Ribeiro Bampi
- Postgraduate Program in Biotechnology, Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Angela Maria Casaril
- Postgraduate Program in Biotechnology, Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Mariana G Fronza
- Postgraduate Program in Biotechnology, Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Micaela Domingues
- Postgraduate Program in Biotechnology, Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Beatriz Vieira
- Postgraduate Program in Chemistry, Laboratory of Clean Organic Synthesis, Center of Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, RS, Brazil
| | - Karine Rech Begnini
- Postgraduate Program in Biotechnology, Molecular and Cellular Oncology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Fabiana K Seixas
- Postgraduate Program in Biotechnology, Molecular and Cellular Oncology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Tiago Veiras Collares
- Postgraduate Program in Biotechnology, Molecular and Cellular Oncology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Eder João Lenardão
- Postgraduate Program in Chemistry, Laboratory of Clean Organic Synthesis, Center of Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Postgraduate Program in Biotechnology, Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil.
| |
Collapse
|
12
|
Fronza MG, Baldinotti R, Fetter J, Sacramento M, Sousa FSS, Seixas FK, Collares T, Alves D, Praticò D, Savegnago L. QTC-4-MeOBnE Rescues Scopolamine-Induced Memory Deficits in Mice by Targeting Oxidative Stress, Neuronal Plasticity, and Apoptosis. ACS Chem Neurosci 2020; 11:1259-1269. [PMID: 32227985 DOI: 10.1021/acschemneuro.9b00661] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Cognitive decline and memory impairment induced by disruption of cholinergic neurons and oxidative brain damage are among the earliest pathological hallmark signatures of Alzheimer's disease. Scopolamine is a postsynaptic muscarinic receptor blocker which causes impairment of cholinergic transmission resulting in cognitive deficits. Herein we investigated the effect of QTC-4-MeOBnE (1-(7-chloroquinolin-4-yl)-N-(4-methoxybenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide) on memory impairments in mice chronically treated with scopolamine and the molecular mechanisms involved. Administration of scopolamine (1 mg/kg) for 15 days resulted in significant impairments in working and short-term memory in mice, as assessed by the novel object recognition and the Y-maze paradigms. However, both deficits were prevented if mice receiving the scopolamine were also treated with QTC-4-MeOBnE. This effect was associated with an increase in antioxidant enzymes (superoxide dismutase and catalase), a reduction in lipid peroxidation, and an increase in Nrf2 expression. Moreover, brains from QTC-4-MeOBnE treated mice had a significant decrease in acetylcholinesterase activity and glycogen synthase kinase-3β levels but an increase in brain-derived neurotrophic factor and Bcl-2 expression levels. Taken together our findings demonstrate that the beneficial effect of QTC-4-MeOBnE in a mouse model of scopolamine-induced memory impairment is mediated via the involvement of different molecular pathways including oxidative stress, neuroplasticity, neuronal vulnerability, and apoptosis. Our study provides further evidence on the promising therapeutic potential of QTC-4-MeOBnE as a multifactorial disease modifying drug in AD and related dementing disorders.
Collapse
Affiliation(s)
- Mariana G. Fronza
- Neurobiotechnology Research Group - GPN, Federal University of Pelotas - UFPel, Technological Development Center, Pelotas, RS 96160-000, Brazil
| | - Rodolfo Baldinotti
- Neurobiotechnology Research Group - GPN, Federal University of Pelotas - UFPel, Technological Development Center, Pelotas, RS 96160-000, Brazil
| | - Jenifer Fetter
- Neurobiotechnology Research Group - GPN, Federal University of Pelotas - UFPel, Technological Development Center, Pelotas, RS 96160-000, Brazil
| | - Manoela Sacramento
- Laboratory of Clean Organic Synthesis - LASOL, Federal University of Pelotas - UFPel, Chemical, Pharmaceutical and Food Science Center, Pelotas, RS 96160-000, Brazil
| | - Fernanda Severo Sabedra Sousa
- Oncology Research Group - GPO, CDTec, Federal University of Pelotas - UFPel, Technological Development Center, Pelotas, RS 96160-000, Brazil
| | - Fabiana K. Seixas
- Oncology Research Group - GPO, CDTec, Federal University of Pelotas - UFPel, Technological Development Center, Pelotas, RS 96160-000, Brazil
| | - Tiago Collares
- Oncology Research Group - GPO, CDTec, Federal University of Pelotas - UFPel, Technological Development Center, Pelotas, RS 96160-000, Brazil
| | - Diego Alves
- Laboratory of Clean Organic Synthesis - LASOL, Federal University of Pelotas - UFPel, Chemical, Pharmaceutical and Food Science Center, Pelotas, RS 96160-000, Brazil
| | - Domenico Praticò
- Alzheimer’s Center at Temple − ACT, Temple University, Lewis Katz School of Medicine, Philadelphia, Pennsylvania 19140, United States
| | - Lucielli Savegnago
- Neurobiotechnology Research Group - GPN, Federal University of Pelotas - UFPel, Technological Development Center, Pelotas, RS 96160-000, Brazil
| |
Collapse
|
13
|
Costa GP, Baldinotti RSM, Fronza MG, Nascimento JER, Dias ÍFC, Sonego MS, Seixas FK, Collares T, Perin G, Jacob RG, Savegnago L, Alves D. Synthesis, Molecular Docking, and Preliminary Evaluation of 2-(1,2,3-Triazoyl)benzaldehydes As Multifunctional Agents for the Treatment of Alzheimer's Disease. ChemMedChem 2020; 15:610-622. [PMID: 32012463 DOI: 10.1002/cmdc.201900622] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2019] [Revised: 01/20/2020] [Indexed: 12/11/2022]
Abstract
We described here our results on the use of thiourea as a ligand in the copper catalysed azide-alkyne cycloaddition (CuAAC) of 2-azidobenzaldehyde with alkynes. Reactions were performed reacting 2-azidobenzaldehyde with a range of terminal alkynes using 10 mol % of copper iodide as a catalyst, 20 mol % of thiourea as a ligand, triethylamine as base, DMSO as solvent at 100 °C under nitrogen atmosphere. The corresponding 2-(1H-1,2,3-triazoyl)-benzaldehydes (2-TBH) were obtained in moderated to excellent yields and according our experiments, the use of thiourea decreases the formation of side products. The obtained compounds were screened for their binding affinity with multiple therapeutic targets of AD by molecular docking: β-secretase (BACE), glycogen synthase kinase (GSK-3β) and acetylcholinesterase (AChE). The three compounds with highest affinity, 5 a (2-(4-phenyl-1H-1,2,3-triazol-1-yl)benzaldehyde), 5 b (2-(4-(p-tolyl)-1H-1,2,3-triazol-1-yl)benzaldehyde), and 5 d (2-(4-(4-(tert-butyl)phenyl)-1H-1,2,3-triazol-1-yl)benzaldehyde) were selected and evaluated on its antioxidant effect, in view of select the most promising one to perform the in vivo validation. Due the antioxidant potential ally to the affinity with BACE, GSK-3β and AChE, compound 5 b was evaluated in a mouse model of AD induced by intracerebroventricular injection of streptozotocin (STZ). Our results indicate that 5 b (1 mg/kg) treatment during 20 days is able to reverse the cognitive and memory impairment induced by STZ trough the modulation of AChE activity, amyloid cascade and GSK-3β expression.
Collapse
Affiliation(s)
- Gabriel P Costa
- LASOL-CCQFA, Universidade Federal de Pelotas - UFPel, P.O. Box 354 - 96010-900, Pelotas RS, Brazil
| | - Rodolfo S M Baldinotti
- Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas, Pelotas RS, Brazil
| | - Mariana G Fronza
- Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas, Pelotas RS, Brazil
| | | | - Ítalo F C Dias
- LASOL-CCQFA, Universidade Federal de Pelotas - UFPel, P.O. Box 354 - 96010-900, Pelotas RS, Brazil
| | - Mariana Souza Sonego
- Grupo de Pesquisa em Oncologia, Universidade Federal de Pelotas, Pelotas RS, Brazil
| | | | - Tiago Collares
- Grupo de Pesquisa em Oncologia, Universidade Federal de Pelotas, Pelotas RS, Brazil
| | - Gelson Perin
- LASOL-CCQFA, Universidade Federal de Pelotas - UFPel, P.O. Box 354 - 96010-900, Pelotas RS, Brazil
| | - Raquel G Jacob
- LASOL-CCQFA, Universidade Federal de Pelotas - UFPel, P.O. Box 354 - 96010-900, Pelotas RS, Brazil
| | - Lucielli Savegnago
- Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas, Pelotas RS, Brazil
| | - Diego Alves
- LASOL-CCQFA, Universidade Federal de Pelotas - UFPel, P.O. Box 354 - 96010-900, Pelotas RS, Brazil
| |
Collapse
|
14
|
Krüger R, Iepsen B, Larroza AME, Fronza MG, Silveira CH, Bevilacqua AC, Köhler MH, Piquini PC, Lenardão EJ, Savegnago L, Iglesias BA, Alves D. Symmetrical and Unsymmetrical 4,7-Bis-arylvinyl-benzo-2,1,3-chalcogenodiazoles: Synthesis, Photophysical and Electrochemical Properties and Biomolecular Interaction Studies. European J Org Chem 2020. [DOI: 10.1002/ejoc.201901619] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Roberta Krüger
- LASOL-CCQFA; Universidade Federal de Pelotas UFPel; P.O. Box 354 - 96010-900 Pelotas RS Brazil
| | - Bruna Iepsen
- LASOL-CCQFA; Universidade Federal de Pelotas UFPel; P.O. Box 354 - 96010-900 Pelotas RS Brazil
| | - Allya M. E. Larroza
- LASOL-CCQFA; Universidade Federal de Pelotas UFPel; P.O. Box 354 - 96010-900 Pelotas RS Brazil
| | - Mariana G. Fronza
- Programa de Pós-Graduação em Biotecnologia (PPGB); Universidade Federal de Pelotas UFPel; Pelotas RS Brazil
| | - Carolina H. Silveira
- Departament of Chemistry; Laboratório de Bioinorgânica e Materiais Porfirínicos; Universidade Federal de Santa Maria, UFSM; 97105-900 Santa Maria - RS Brazil
| | - Andressa C. Bevilacqua
- Departamento de Física; Universidade Federal de Santa Maria; 97105-900 Santa Maria RS Brazil
| | - Mateus H. Köhler
- Departamento de Física; Universidade Federal de Santa Maria; 97105-900 Santa Maria RS Brazil
| | - Paulo C. Piquini
- Departamento de Física; Universidade Federal de Santa Maria; 97105-900 Santa Maria RS Brazil
| | - Eder J. Lenardão
- LASOL-CCQFA; Universidade Federal de Pelotas UFPel; P.O. Box 354 - 96010-900 Pelotas RS Brazil
| | - Lucielli Savegnago
- Programa de Pós-Graduação em Biotecnologia (PPGB); Universidade Federal de Pelotas UFPel; Pelotas RS Brazil
| | - Bernardo A. Iglesias
- Departament of Chemistry; Laboratório de Bioinorgânica e Materiais Porfirínicos; Universidade Federal de Santa Maria, UFSM; 97105-900 Santa Maria - RS Brazil
| | - Diego Alves
- LASOL-CCQFA; Universidade Federal de Pelotas UFPel; P.O. Box 354 - 96010-900 Pelotas RS Brazil
| |
Collapse
|
15
|
Neto JSS, Krüger R, Balaguez RA, Fronza MG, Acunha TV, Oliboni RS, Savegnago L, Iglesias BA, Alves D. Synthesis, photophysics and biomolecule interactive studies of new hybrid benzo-2,1,3-thiadiazoles. NEW J CHEM 2020. [DOI: 10.1039/c9nj05932f] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
New hybrid molecules containing benzo-2,1,3-thiadiazole, benzofuran and arylselanyl moieties were synthesized and their photophysics and biomolecule interactive studies were performed.
Collapse
Affiliation(s)
- José S. S. Neto
- Laboratório de Síntese Orgânica Limpa
- Universidade Federal de Pelotas
- Pelotas
- Brazil
| | - Roberta Krüger
- Laboratório de Síntese Orgânica Limpa
- Universidade Federal de Pelotas
- Pelotas
- Brazil
| | - Renata A. Balaguez
- Laboratório de Síntese Orgânica Limpa
- Universidade Federal de Pelotas
- Pelotas
- Brazil
| | - Mariana G. Fronza
- Programa de Pós-Graduação em Biotecnologia (PPGB)
- Grupo de Pesquisa em Neurobiotecnologia – GPN
- Universidade Federal de Pelotas
- Pelotas
- Brazil
| | - Thiago V. Acunha
- Departament of Chemistry
- Laboratório de Bioinorgânica e Materiais Porfirínicos
- Universidade Federal de Santa Maria
- UFSM
- 97115-900 Santa Maria – RS
| | - Robson S. Oliboni
- Grupo de Catálise e Estudos Teóricos
- Universidade Federal de Pelotas
- Pelotas
- Brazil
| | - Lucielli Savegnago
- Programa de Pós-Graduação em Biotecnologia (PPGB)
- Grupo de Pesquisa em Neurobiotecnologia – GPN
- Universidade Federal de Pelotas
- Pelotas
- Brazil
| | - Bernardo A. Iglesias
- Departament of Chemistry
- Laboratório de Bioinorgânica e Materiais Porfirínicos
- Universidade Federal de Santa Maria
- UFSM
- 97115-900 Santa Maria – RS
| | - Diego Alves
- Laboratório de Síntese Orgânica Limpa
- Universidade Federal de Pelotas
- Pelotas
- Brazil
| |
Collapse
|
16
|
Fronza MG, Baldinotti R, Martins MC, Goldani B, Dalberto BT, Kremer FS, Begnini K, Pinto LDS, Lenardão EJ, Seixas FK, Collares T, Alves D, Savegnago L. Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer's disease. Sci Rep 2019; 9:7276. [PMID: 31086208 PMCID: PMC6513848 DOI: 10.1038/s41598-019-43532-9] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2018] [Accepted: 04/23/2019] [Indexed: 11/28/2022] Open
Abstract
Alzheimer’s disease (AD) is a multifactorial pathology characterized by amyloid deposits, neurofibrillary formation, oxidative stress and cholinergic system dysfunction. In this sense, here we report the rational design of a multi-target directed ligand (MTDL) for AD based on virtual screening and bioinformatic analyses, exploring the molecular targets β-secretase (BACE-1), glycogen synthase kinase-3β (GSK-3β) and acetylcholinesterase (AChE). After this screening, the compound with higher molecular docking affinity was selected, the 1-(7-chloroquinolin-4-yl)-N-(4-methoxybenzyl)-5-methyl-1H-1,2,3-triazole-4 carboxamide(QTC-4-MeOBnE). To further our studies, the protective effect of QTC-4-MeOBnE (0.1 and 1 mg/kg for 20 days) on STZ-induced sporadic AD mice was determined. QTC-4-MeOBnE pretreatment attenuated cognitive and memory deficit induced by STZ in an object recognition test, Y-maze, social recognition test and step-down passive avoidance. The mechanisms underlying this action might be attributed to the reduction of lipid peroxidation and reactive species formation in the prefrontal cortex and hippocampus of mice submitted to STZ. In addition, QTC-4-MeOBnE pretreatment abolished the up-regulation of AChE activity and the overexpression of GSK 3β and genes involved in amyloid cascade such as BACE-1, protein precursor amyloid, у-secretase, induced by STZ. Moreover, toxicological parameters were not modified by QTC-4-MeOBnE chronic treatment. This evidence suggests that QTC-4-MeOBnE exerts its therapeutic effect through multiple pathways involved in AD.
Collapse
Affiliation(s)
- Mariana G Fronza
- Research Group on Neurobiotechnology - GPN, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil
| | - Rodolfo Baldinotti
- Research Group on Neurobiotechnology - GPN, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil
| | - Maria Clara Martins
- Research Group on Neurobiotechnology - GPN, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil
| | - Bruna Goldani
- Laboratory of Clean Organic Synthesis - LASOL, CCQFA, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Bianca Thaís Dalberto
- Laboratory of Clean Organic Synthesis - LASOL, CCQFA, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Frederico Schmitt Kremer
- Laboratory of Bioinformatics and Proteomics - BIOPRO-LAB, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil
| | - Karine Begnini
- Oncology Research Group - GPO, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil
| | - Luciano da Silva Pinto
- Laboratory of Bioinformatics and Proteomics - BIOPRO-LAB, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil
| | - Eder João Lenardão
- Laboratory of Clean Organic Synthesis - LASOL, CCQFA, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Fabiana K Seixas
- Oncology Research Group - GPO, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil
| | - Tiago Collares
- Oncology Research Group - GPO, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil
| | - Diego Alves
- Laboratory of Clean Organic Synthesis - LASOL, CCQFA, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Research Group on Neurobiotechnology - GPN, CDTec, Federal University of Pelotas, UFPel, Pelotas, RS, Brazil.
| |
Collapse
|
17
|
Fonseca SF, Padilha NB, Thurow S, Roehrs JA, Savegnago L, de Souza MN, Fronza MG, Collares T, Buss J, Seixas FK, Alves D, Lenardão EJ. Ultrasound-promoted copper-catalyzed synthesis of bis-arylselanyl chrysin derivatives with boosted antioxidant and anticancer activities. Ultrason Sonochem 2017; 39:827-836. [PMID: 28733012 DOI: 10.1016/j.ultsonch.2017.06.007] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/11/2017] [Revised: 06/08/2017] [Accepted: 06/09/2017] [Indexed: 05/21/2023]
Abstract
Herein we report the use of ultrasonic irradiation (US) in the synthesis of six new semi-synthetic selenium-containing chrysin derivatives by a simple and effective methodology utilizing CuI as catalyst, in good to excellent yields (60-89%). It was observed that US accelerates the reaction compared to conventional heating with excellent selectivity for diselenylated products. Compounds were tested for their antioxidant and anticancer activities in vitro and it was observed that the presence of selenium in the A-ring of chrysin enhanced both antioxidant and anticancer properties. Semi-synthetic 6,8-bis(o-tolylselanyl)-chrysin 3b has the best radical scavenging activity of DPPH (Imax: 39.79µM) and ABTS+ (IC50: 6.5µM) radicals. Similarly, in the Reactive Species (RS) assay, 3b showed high antioxidant activity in mice cortex (IC50: 5.67µM), whereas 6,8-bis(p-anisoylselanyl)-chrysin 3c was the more active in the hippocampus (IC50: 5.63µM). The Se-chrysins were effective in prevention of lipid peroxidation, highlighting 6,8-bis(p-fluorophenylselanyl)-chrysin 3d in cortex (IC50: 0.54µM) and 3b in hippocampus (IC50: 0.27µM). In addition, 3d was effective in inhibiting human lung adenocarcinoma (A549) cells growth, with a IC50 of 19.9µM after 72h of treatment, while 6,8-bis(p-anisoylselanyl)-chrysin 3c presented the higher antiproliferative activity after 48h of treatment (IC50 of 41.4µM).
Collapse
Affiliation(s)
- Sergio F Fonseca
- Laboratório de Síntese Orgânica Limpa - LASOL, Universidade Federal de Pelotas - UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil
| | - Nathalia B Padilha
- Laboratório de Síntese Orgânica Limpa - LASOL, Universidade Federal de Pelotas - UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil
| | - Samuel Thurow
- Laboratório de Síntese Orgânica Limpa - LASOL, Universidade Federal de Pelotas - UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil
| | - Juliano A Roehrs
- Laboratório de Síntese Orgânica Limpa - LASOL, Universidade Federal de Pelotas - UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Grupo de Pesquisa em Neurobiotecnologia - GPN, Universidade Federal de Pelotas - UFPel, 96010-900 Pelotas, RS, Brazil
| | - Maurice N de Souza
- Grupo de Pesquisa em Neurobiotecnologia - GPN, Universidade Federal de Pelotas - UFPel, 96010-900 Pelotas, RS, Brazil
| | - Mariana G Fronza
- Grupo de Pesquisa em Neurobiotecnologia - GPN, Universidade Federal de Pelotas - UFPel, 96010-900 Pelotas, RS, Brazil
| | - Tiago Collares
- Laboratório de Biotecnologia do Câncer, Universidade Federal de Pelotas - UFPel, 96010-900 Pelotas, RS, Brazil
| | - Julieti Buss
- Laboratório de Biotecnologia do Câncer, Universidade Federal de Pelotas - UFPel, 96010-900 Pelotas, RS, Brazil
| | - Fabiana K Seixas
- Laboratório de Biotecnologia do Câncer, Universidade Federal de Pelotas - UFPel, 96010-900 Pelotas, RS, Brazil
| | - Diego Alves
- Laboratório de Síntese Orgânica Limpa - LASOL, Universidade Federal de Pelotas - UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil
| | - Eder J Lenardão
- Laboratório de Síntese Orgânica Limpa - LASOL, Universidade Federal de Pelotas - UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil.
| |
Collapse
|
18
|
Pinto Brod LM, Fronza MG, Vargas JP, Lüdtke DS, Brüning CA, Savegnago L. Modulation of PKA, PKC, CAMKII, ERK 1/2 pathways is involved in the acute antidepressant-like effect of (octylseleno)-xylofuranoside (OSX) in mice. Psychopharmacology (Berl) 2017; 234:717-725. [PMID: 27995278 DOI: 10.1007/s00213-016-4505-5] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 12/09/2016] [Indexed: 12/13/2022]
Abstract
RATIONALE (Octylseleno)-xylofuranoside (OSX) is an organoselenium compound from the class of alkylseleno carbohydrates possessing a C8 alkyl chain. Members of this class of organoselenium compounds have promising pharmacological activities, among them are antioxidant and acute antidepressant-like activities with the involvement of monoaminergic system, as previously presented by our research group. OBJECTIVE The objective of the study was to investigate the possible involvement of cellular signalling pathways in the antidepressant-like effect caused by OSX (0.01 mg/kg, oral route (p.o.) by gavage) in the tail suspension test (TST) in mice. METHODS Mice were treated by intracerebroventricular (i.c.v.) injection either with vehicle or with H-89 (1 μg/site i.c.v., an inhibitor of protein kinase A-PKA), KN-62 (1 μg/site i.c.v., an inhibitor of Ca2+/calmodulin-dependent protein kinase II-CAMKII), chelerythrine (1 μg/site i.c.v., an inhibitor of protein kinase C-PKC) or PD098059 (5 μg/site i.c.v., an inhibitor of extracellular-regulated protein kinase 1/2-ERK1/2). Fifteen minutes after, vehicle or OSX was injected, and 30 min later, the TST and open field tests (OFT) were carried out. RESULTS The antidepressant-like effect of orally administered OSX was blocked by treatment of the mice with H-89, KN-62, chelerythrine and PD098059; all inhibitors of signalling proteins involved with neurotrophic signalling pathways. The number of crossings in the OFT was not altered by treatment with OSX and/or signalling antagonists. CONCLUSIONS The results demonstrated that OSX showed an antidepressant-like effect in the TST in mice through the activation of protein kinases PKA, PKC, CAMKII and ERK1/2 that are involved in intracellular signalling pathways.
Collapse
Affiliation(s)
- Lucimar M Pinto Brod
- Programa de Pós Graduação em Biotecnologia, PPGBiotec, Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil
| | - Mariana G Fronza
- Programa de Pós Graduação em Biotecnologia, PPGBiotec, Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil
| | - Jaqueline Pinto Vargas
- Instituto de Química, Universidade Federal do Rio Grande do Sul, UFRGS, Av. Bento Gonçalves 9500, Porto Alegre, RS, 91501-970, Brazil
| | - Diogo S Lüdtke
- Instituto de Química, Universidade Federal do Rio Grande do Sul, UFRGS, Av. Bento Gonçalves 9500, Porto Alegre, RS, 91501-970, Brazil
| | - César Augusto Brüning
- Núcleo de Síntese, Aplicação e Análise de Compostos Orgânicos e Inorgânicos, Universidade Federal da Fronteira Sul, Cerro Largo, RS, Brazil
| | - Lucielli Savegnago
- Programa de Pós Graduação em Biotecnologia, PPGBiotec, Grupo de Pesquisa em Neurobiotecnologia - GPN, CDTec, Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil. .,Programa de Pós Graduação em Bioquímica e Bioprospecção, PPGBBio, Grupo de Pesquisa em Neurobiotecnologia - GPN, CCQFA, Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil.
| |
Collapse
|
19
|
Savegnago L, Sacramento MD, Brod LMP, Fronza MG, Seus N, Lenardão EJ, Paixão MW, Alves D. Phenylselanyl-1H-1,2,3-triazole-4-carbonitriles: synthesis, antioxidant properties and use as precursors to highly functionalized tetrazoles. RSC Adv 2016. [DOI: 10.1039/c5ra22445d] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
We describe herein our results on the synthesis, antioxidant properties and chemical diversification of phenylselanyl-1H-1,2,3-triazole-4-carbonitriles.
Collapse
Affiliation(s)
- Lucielli Savegnago
- Grupo de Pesquisa em Neurobiotecnologia – GPN
- CDTec
- Universidade Federal de Pelotas
- UFPel
- Pelotas
| | - Manoela do Sacramento
- Laboratório de Síntese Orgânica Limpa – LASOL – CCQFA – Universidade Federal de Pelotas – UFPel
- Pelotas
- Brazil
| | - Lucimar M. P. Brod
- Grupo de Pesquisa em Neurobiotecnologia – GPN
- CDTec
- Universidade Federal de Pelotas
- UFPel
- Pelotas
| | - Mariana G. Fronza
- Grupo de Pesquisa em Neurobiotecnologia – GPN
- CDTec
- Universidade Federal de Pelotas
- UFPel
- Pelotas
| | - Natália Seus
- Laboratório de Síntese Orgânica Limpa – LASOL – CCQFA – Universidade Federal de Pelotas – UFPel
- Pelotas
- Brazil
| | - Eder J. Lenardão
- Laboratório de Síntese Orgânica Limpa – LASOL – CCQFA – Universidade Federal de Pelotas – UFPel
- Pelotas
- Brazil
| | - Márcio W. Paixão
- Laboratório de Síntese de Produtos Naturais
- Universidade Federal de São Carlos
- São Carlos 13565-905
- Brazil
| | - Diego Alves
- Grupo de Pesquisa em Neurobiotecnologia – GPN
- CDTec
- Universidade Federal de Pelotas
- UFPel
- Pelotas
| |
Collapse
|